---

Alan Scott

Alan Scott was first to apply tiny doses of botulinum toxin type A toxin to treat ‘crossed eyes’ (strabismus) and ‘uncontrollable blinking’ (blepharospasm), confirming his idea that weakening the muscles that pull crossed eyes inward would be an effective treatment. Allergan bought the rights to the drug and received FDA approval in 1989; it was renamed Botox.

---

Part of the Power List 2014

The 100 most influential people

Who are the 100 most influential people in ophthalmology?
That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2014